- Home
- GNE vs ABEO Comparison
GNE vs ABEO Comparison
Compare GNE & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNE | ABEO |
|---|---|---|
| Founded | 2011 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.1M | 320.3M |
| IPO Year | 2011 | 2005 |
Fundamental Metrics
Financial Performance| Metric | GNE | ABEO |
|---|---|---|
| Price | $14.55 | $5.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $16.00 | ★ $20.00 |
| AVG Volume (30 Days) | 75.2K | ★ 1.0M |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | 95.65 | ★ 165.16 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $425,202,000.00 | $2,998,000.00 |
| Revenue This Year | $17.49 | $1,024.31 |
| Revenue Next Year | $7.07 | $145.42 |
| P/E Ratio | $128.64 | ★ N/A |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $12.69 | $4.00 |
| 52 Week High | $28.08 | $7.54 |
Technical Indicators
Market Signals| Indicator | GNE | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 50.96 |
| Support Level | $13.44 | $5.24 |
| Resistance Level | $14.75 | $5.64 |
| Average True Range (ATR) | 0.41 | 0.21 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 77.14 | 57.81 |
Price Performance
Historical ComparisonAbout GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.